AbCellera Biologics Newsroom

Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating

Moomoo NewsNov 7 09:35 ET

Bloom Burton Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 6 13:31 ET

A Quick Look at Today's Ratings for AbCellera Biologics(ABCL.US), With a Forecast Between $7 to $12

Moomoo NewsNov 6 08:08 ET

AbCellera Biologics Analyst Ratings

BenzingaNov 5 10:47 ET

Benchmark Co. Maintains AbCellera Biologics(ABCL.US) With Hold Rating

Moomoo NewsNov 5 07:34 ET

TD Cowen Initiates AbCellera Biologics(ABCL.US) With Buy Rating

Moomoo NewsNov 4 21:34 ET

TD Cowen Remains a Buy on AbCellera Biologics (ABCL)

TipRanksNov 4 21:28 ET

KeyBanc Maintains AbCellera Biologics(ABCL.US) With Buy Rating

Moomoo NewsAug 23 03:31 ET

Benchmark Co. Downgrades AbCellera Biologics(ABCL.US) to Hold Rating

Moomoo NewsAug 20 07:33 ET

Strong Liquidity and Strategic Alliances Underpin Buy Rating for AbCellera Biologics

TipRanksAug 9 06:04 ET

Understanding the Buy Rating: A Synopsis of AbCellera Biologics' Investment Potential

TipRanksAug 8 10:00 ET

TD Cowen Maintains AbCellera Biologics(ABCL.US) With Buy Rating

Moomoo NewsAug 6 23:32 ET

TD Cowen Remains a Buy on AbCellera Biologics (ABCL)

TipRanksAug 6 22:57 ET

KeyBanc Adjusts Price Target on AbCellera Biologics to $5 From $7, Maintains Overweight Rating

MT NewswiresJul 11 09:38 ET

AbCellera Biologics Analyst Ratings

BenzingaJul 11 07:20 ET

KeyBanc Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)

TipRanksMay 16 02:30 ET

Analysts Offer Insights on Healthcare Companies: Certara (CERT), Exact Sciences (EXAS) and AbCellera Biologics (ABCL)

TipRanksMay 10 01:55 ET

AbCellera Biologics Analyst Ratings

BenzingaMay 8 14:20 ET

Keybanc Maintains Overweight on AbCellera Biologics, Lowers Price Target to $7

BenzingaMay 8 14:20 ET

Analysts Are Bullish on These Healthcare Stocks: ICU Medical (ICUI), AbCellera Biologics (ABCL)

TipRanksMay 8 03:15 ET